MA32170B1 - Nouveaux derives d'aminomethylbenzene - Google Patents
Nouveaux derives d'aminomethylbenzeneInfo
- Publication number
- MA32170B1 MA32170B1 MA33206A MA33206A MA32170B1 MA 32170 B1 MA32170 B1 MA 32170B1 MA 33206 A MA33206 A MA 33206A MA 33206 A MA33206 A MA 33206A MA 32170 B1 MA32170 B1 MA 32170B1
- Authority
- MA
- Morocco
- Prior art keywords
- aminomethylpenzene
- new derivatives
- derivatives
- novel
- groups
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical class NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Otolaryngology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Abstract
L'invention concerne de nouveaux dérivés d'aminométhylbenzène, leur préparation et leur utilisation comme composés pharmaceutiquement actifs. Lesdits composés agissent en particulier comme des agents immunomodulateurs. (i) dans laquelle a représente un des groupes (i), (i), (i) et (i).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2008050841 | 2008-03-07 | ||
PCT/IB2009/050844 WO2009109904A1 (fr) | 2008-03-07 | 2009-03-03 | Nouveaux dérivés d'aminométhylbenzène |
Publications (1)
Publication Number | Publication Date |
---|---|
MA32170B1 true MA32170B1 (fr) | 2011-03-01 |
Family
ID=40578509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA33206A MA32170B1 (fr) | 2008-03-07 | 2010-09-29 | Nouveaux derives d'aminomethylbenzene |
Country Status (18)
Country | Link |
---|---|
US (1) | US8410151B2 (fr) |
EP (1) | EP2262782B1 (fr) |
JP (1) | JP5481395B2 (fr) |
KR (1) | KR20100125380A (fr) |
CN (1) | CN102007107B (fr) |
AR (1) | AR070819A1 (fr) |
AU (1) | AU2009220893A1 (fr) |
BR (1) | BRPI0910288A2 (fr) |
CA (1) | CA2715317A1 (fr) |
ES (1) | ES2389469T3 (fr) |
IL (1) | IL207973A0 (fr) |
MA (1) | MA32170B1 (fr) |
MX (1) | MX2010009645A (fr) |
NZ (1) | NZ588439A (fr) |
RU (1) | RU2010140847A (fr) |
TW (1) | TW200942524A (fr) |
WO (1) | WO2009109904A1 (fr) |
ZA (1) | ZA201007137B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2009002233A (es) * | 2006-09-07 | 2009-03-16 | Actelion Pharmaceuticals Ltd | Derivados de piridin-4-il como agentes inmunomoduladores. |
EP2069335B1 (fr) * | 2006-09-08 | 2012-12-26 | Actelion Pharmaceuticals Ltd. | Dérivés de pyridin-3-yle en tant qu'agents immunomodulateurs |
AU2007298593A1 (en) * | 2006-09-21 | 2008-03-27 | Actelion Pharmaceuticals Ltd | Phenyl derivatives and their use as immunomodulators |
ES2450750T3 (es) * | 2007-03-16 | 2014-03-25 | Actelion Pharmaceuticals Ltd. | Derivados de amino-piridina como agonistas del receptor S1P1/EDG1 |
ES2361463T3 (es) * | 2007-08-17 | 2011-06-17 | Actelion Pharmaceuticals Ltd. | Derivados de piridina como moduladores del receptor s1p1/edg1. |
RU2010121969A (ru) * | 2007-11-01 | 2011-12-10 | Актелион Фармасьютиклз Лтд (Ch) | Новые производные пиримидина |
US8575200B2 (en) * | 2008-03-07 | 2013-11-05 | Actelion Pharmaceuticals Ltd | Pyridin-2-yl derivatives as immunomodulating agents |
AR077413A1 (es) | 2009-07-16 | 2011-08-24 | Actelion Pharmaceuticals Ltd | Derivados piridin-4-ilo |
TW201120016A (en) * | 2009-12-08 | 2011-06-16 | Abbott Lab | Novel oxadiazole compounds |
DK2665720T3 (en) | 2011-01-19 | 2015-07-13 | Actelion Pharmaceuticals Ltd | 2-methoxy-pyridin-4-yl-yl derivatives |
WO2013036530A1 (fr) | 2011-09-08 | 2013-03-14 | Allergan, Inc. | Modulateurs de récepteurs de 3-(4-(5-phényl-1,2,4-oxadiazol-3-yl)phénoxy)propan-2-ol en tant que modulateurs de récepteurs de sphingosine-1-phosphate |
PT2970236T (pt) | 2013-03-15 | 2017-11-30 | Idorsia Pharmaceuticals Ltd | Derivados de piridin-4-ilo |
HUE047646T2 (hu) | 2015-05-20 | 2020-05-28 | Idorsia Pharmaceuticals Ltd | Az (S)-3-{4-[5-(2-ciklopentil-6-metoxi-piridin-4-il)-[1,2,4]oxadiazol-3-il]-2-etil-6-metil-fenoxi} -propán-1,2-diol vegyület kristályformája |
CN108047025B (zh) * | 2017-12-29 | 2020-08-04 | 珠海奥博凯生物医药技术有限公司 | 一种3-醛基-5-甲基苯甲酸的制备方法 |
CN112707809B (zh) * | 2020-12-30 | 2023-08-29 | 丽珠集团新北江制药股份有限公司 | 一种制备噁唑啉杀虫剂氟雷拉纳中间体的方法 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991015583A1 (fr) | 1990-04-05 | 1991-10-17 | The American National Red Cross | Famille de proteines apparentee a une proteine precoce immediate exprimee par des cellules endotheliales humaines durant la differenciation |
TW414795B (en) * | 1996-07-01 | 2000-12-11 | Yamanouchi Pharma Co Ltd | A thiophene derivative and the pharmaceutical composition |
WO1999046277A1 (fr) | 1998-03-09 | 1999-09-16 | Smithkline Beecham Corporation | POLYNUCLEOTIDES ET POLYPEPTIDES D'EDG-1c HUMAIN ET LEURS PROCEDES D'UTILISATION |
BR0013427A (pt) | 1999-08-19 | 2002-07-30 | Nps Pharma Inc | Compostos heteropolicìclicos e seus usos como antagonistas no receptor de glutamato metabotrópico |
CA2431904A1 (fr) | 2000-12-20 | 2002-08-01 | Merck & Co., Inc. | Agents inhibiteurs de p38 kinase (halo-benzo carbonyl)heterocyclo- fusionnes phenyl |
JP2003034684A (ja) * | 2001-06-29 | 2003-02-07 | Biofor Inc | 新規な種類の抗真菌剤 |
ATE448193T1 (de) | 2002-01-18 | 2009-11-15 | Merck & Co Inc | ßN-(BENZYL)AMINOALKYL CARBOXYLATE, PHOSPHINATE, PHOSPHONATE UND TETRAZOLE ALS EDG REZEPTORAGONISTENß |
JP4430941B2 (ja) | 2002-01-18 | 2010-03-10 | メルク エンド カムパニー インコーポレーテッド | Edg受容体作動薬 |
CA2488117A1 (fr) * | 2002-06-17 | 2003-12-24 | Merck & Co., Inc. | 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates et 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates utilises en tant qu'agonistes du recepteur edg |
WO2004035538A1 (fr) * | 2002-10-15 | 2004-04-29 | Merck & Co., Inc. | Procede de fabrication de l'acide azetidine-3-carboxylique |
WO2005014525A2 (fr) | 2003-08-12 | 2005-02-17 | Mitsubishi Pharma Corporation | Compose bi-aryle presentant une activite immunosuppressive |
EP1670463A2 (fr) | 2003-10-01 | 2006-06-21 | Merck & Co., Inc. | 1,2,4-oxadiazoles substitues 3,5-aryle, heteroaryle ou cycloalkyle servant d'agonistes du recepteur s1p |
US7605171B2 (en) | 2003-12-17 | 2009-10-20 | Merck & Co., Inc. | (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists |
WO2005115382A1 (fr) | 2004-05-29 | 2005-12-08 | 7Tm Pharma A/S | Ligands des recepteurs crth2 a usages medicaux |
EP1760071A4 (fr) * | 2004-06-23 | 2008-03-05 | Ono Pharmaceutical Co | Composé ayant une activité de liaison aux récepteurs s1p et utilisation de celui-ci |
WO2006047195A2 (fr) | 2004-10-22 | 2006-05-04 | Merck & Co., Inc. | Carboxylates, sulfonates, phosphonates, phosphinates 2-(aryl)azacyclylmethyle et heterocycles utilises comme agonistes des recepteurs s1p |
EP1873153B1 (fr) | 2005-04-22 | 2010-07-07 | Daiichi Sankyo Company, Limited | Derives d'acide 3-azetidinecarboxylique utiles en tant qu'immunosuppresseurs |
AU2006239418A1 (en) | 2005-04-26 | 2006-11-02 | Neurosearch A/S | Novel oxadiazole derivatives and their medical use |
BRPI0612028A2 (pt) * | 2005-06-08 | 2010-10-13 | Novartis Ag | oxadiazóis ou isodiazóis policìclicos e uso dos mesmos como ligantes de receptor s1p |
WO2007001973A1 (fr) | 2005-06-28 | 2007-01-04 | Astrazeneca Ab | Utilisation |
TWI404706B (zh) * | 2006-01-11 | 2013-08-11 | Actelion Pharmaceuticals Ltd | 新穎噻吩衍生物 |
GB0601744D0 (en) | 2006-01-27 | 2006-03-08 | Novartis Ag | Organic compounds |
RU2008137553A (ru) | 2006-02-21 | 2010-03-27 | Юниверсити Оф Вирджиния Пэтент Фаундейшн (Us) | Фенил-циклоалкильные соединения, содержащие гетероциклические структуры |
WO2007132307A1 (fr) * | 2006-05-09 | 2007-11-22 | Pfizer Products Inc. | Dérivés d'acide cycloalkylaminé et compositions pharmaceutiques à base de ceux-ci |
AR061841A1 (es) * | 2006-09-07 | 2008-09-24 | Actelion Pharmaceuticals Ltd | Derivados de tiofen-oxadiazoles, agonistas del receptor s1p1/edg1, composiciones farmaceuticas que los contienen y usos como agentes inmunomoduladores. |
MX2009002233A (es) * | 2006-09-07 | 2009-03-16 | Actelion Pharmaceuticals Ltd | Derivados de piridin-4-il como agentes inmunomoduladores. |
EP2069335B1 (fr) * | 2006-09-08 | 2012-12-26 | Actelion Pharmaceuticals Ltd. | Dérivés de pyridin-3-yle en tant qu'agents immunomodulateurs |
AU2007298593A1 (en) * | 2006-09-21 | 2008-03-27 | Actelion Pharmaceuticals Ltd | Phenyl derivatives and their use as immunomodulators |
AU2007302262A1 (en) * | 2006-09-29 | 2008-04-03 | Novartis Ag | Oxadiazole derivatives with anti-inflammatory and immunosuppressive properties |
JP2008120794A (ja) | 2006-10-16 | 2008-05-29 | Daiichi Sankyo Co Ltd | ヘテロ環化合物を含有する医薬組成物 |
NZ577111A (en) * | 2006-12-15 | 2012-05-25 | Abbott Lab | Novel oxadiazole compounds |
WO2008091967A1 (fr) | 2007-01-26 | 2008-07-31 | Smithkline Beecham Corporation | Composés chimiques |
ES2450750T3 (es) * | 2007-03-16 | 2014-03-25 | Actelion Pharmaceuticals Ltd. | Derivados de amino-piridina como agonistas del receptor S1P1/EDG1 |
EP2193126B1 (fr) | 2007-10-04 | 2015-06-24 | Merck Serono S.A. | Composés d'oxadiazole diaryle |
CA2696863C (fr) | 2007-10-04 | 2016-10-18 | Anna Quattropani | Derives d'oxadiazole |
RU2010121969A (ru) * | 2007-11-01 | 2011-12-10 | Актелион Фармасьютиклз Лтд (Ch) | Новые производные пиримидина |
WO2009060278A1 (fr) | 2007-11-08 | 2009-05-14 | Pfizer Inc. | Dérivés d'acide cyclobutylcarboxylique |
TW200930363A (en) * | 2007-12-10 | 2009-07-16 | Actelion Pharmaceuticals Ltd | Novel thiophene derivatives |
EP2262799B1 (fr) * | 2008-03-06 | 2012-07-04 | Actelion Pharmaceuticals Ltd. | Composés de pyridine |
MY156381A (en) | 2008-05-14 | 2016-02-15 | Scripps Research Inst | Novel modulators of sphingosine phosphate receptors |
AR077413A1 (es) | 2009-07-16 | 2011-08-24 | Actelion Pharmaceuticals Ltd | Derivados piridin-4-ilo |
-
2009
- 2009-03-03 NZ NZ588439A patent/NZ588439A/en not_active IP Right Cessation
- 2009-03-03 US US12/920,574 patent/US8410151B2/en not_active Expired - Fee Related
- 2009-03-03 EP EP09718505A patent/EP2262782B1/fr not_active Not-in-force
- 2009-03-03 RU RU2010140847/04A patent/RU2010140847A/ru unknown
- 2009-03-03 WO PCT/IB2009/050844 patent/WO2009109904A1/fr active Application Filing
- 2009-03-03 JP JP2010549231A patent/JP5481395B2/ja not_active Expired - Fee Related
- 2009-03-03 CA CA2715317A patent/CA2715317A1/fr not_active Abandoned
- 2009-03-03 BR BRPI0910288A patent/BRPI0910288A2/pt not_active IP Right Cessation
- 2009-03-03 ES ES09718505T patent/ES2389469T3/es active Active
- 2009-03-03 MX MX2010009645A patent/MX2010009645A/es unknown
- 2009-03-03 AU AU2009220893A patent/AU2009220893A1/en not_active Abandoned
- 2009-03-03 KR KR1020107021958A patent/KR20100125380A/ko not_active Application Discontinuation
- 2009-03-03 CN CN200980107967.7A patent/CN102007107B/zh not_active Expired - Fee Related
- 2009-03-06 AR ARP090100810A patent/AR070819A1/es unknown
- 2009-03-06 TW TW098107433A patent/TW200942524A/zh unknown
-
2010
- 2010-09-05 IL IL207973A patent/IL207973A0/en unknown
- 2010-09-29 MA MA33206A patent/MA32170B1/fr unknown
- 2010-10-06 ZA ZA2010/07137A patent/ZA201007137B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2262782A1 (fr) | 2010-12-22 |
AU2009220893A1 (en) | 2009-09-11 |
IL207973A0 (en) | 2010-12-30 |
NZ588439A (en) | 2012-05-25 |
ES2389469T3 (es) | 2012-10-26 |
BRPI0910288A2 (pt) | 2019-09-24 |
US8410151B2 (en) | 2013-04-02 |
EP2262782B1 (fr) | 2012-07-04 |
MX2010009645A (es) | 2010-09-28 |
TW200942524A (en) | 2009-10-16 |
KR20100125380A (ko) | 2010-11-30 |
RU2010140847A (ru) | 2012-04-20 |
CN102007107B (zh) | 2014-07-23 |
JP5481395B2 (ja) | 2014-04-23 |
JP2011513383A (ja) | 2011-04-28 |
US20110028449A1 (en) | 2011-02-03 |
WO2009109904A1 (fr) | 2009-09-11 |
AR070819A1 (es) | 2010-05-05 |
CN102007107A (zh) | 2011-04-06 |
CA2715317A1 (fr) | 2009-09-11 |
ZA201007137B (en) | 2012-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA32170B1 (fr) | Nouveaux derives d'aminomethylbenzene | |
MA31953B1 (fr) | Nouveaux derives du thiophene. | |
MA30717B1 (fr) | Derives de pyridin-3-yle en tant qu'agents immunomodulateurs | |
MA30718B1 (fr) | Derives de pyridin-4-yle en tant qu'agents immunomodulateurs. | |
MA31849B1 (fr) | Nouveaux dérivés de pyrimidine | |
MA33528B1 (fr) | Derives pyridin-4-yliques | |
EA200801998A1 (ru) | ПИРИДИН[3,4-b]ПИРАЗИНОНЫ | |
MA31290B1 (fr) | Derives d'amino-pyridine comme agonistes du recepteur s1p1/edg1 | |
WO2007120647A3 (fr) | Compositions utiles en tant qu'inhibiteurs de canaux sodiques sensibles a la tension | |
MA32729B1 (fr) | Derives d'acide 1-amino-2-cyclobutylethylboronique | |
EA201170703A1 (ru) | Производные адамантилбензамида | |
MA33178B1 (fr) | Pipéridines substituées comme antagonistes de ccr3 | |
MA31906B1 (fr) | Inhibiteurs de la replication du virus de limmunodeficience humaine | |
MA30226B1 (fr) | Agents cytotoxiques comprenant de nouveaux derives de tomaymycine et leur utilisation therapeutique. | |
TW200626610A (en) | Analogs of 17-hydroxywortmannin as PI3K inhibitors | |
MA32351B1 (fr) | Derives d'aminodihydrothiazine a titre d'inhibiteurs de bace pour le traitement de la maladie d'alzheimer | |
WO2006004684A8 (fr) | 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de la chimiokine | |
EA200701114A1 (ru) | Азоловые производные с антимускариновой активностью | |
EA200602243A1 (ru) | 3-аминоциклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов | |
MX2007004699A (es) | Derivados de indol y bencimidazol. | |
UA83875C2 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
MA30765B1 (fr) | Derives innovants du thiophene | |
WO2005115392A3 (fr) | 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides utilises comme modulateurs des recepteurs de la chimiokine | |
MY147949A (en) | Hydrogenated benzo[c]thiophene derivatives as immunomodulators | |
MA29857B1 (fr) | Derives de triazolopyridine en tant qu'inhibiteurs de lipases et phospholipases |